Updated Jul 16, 2026
Dreismann Heinrich has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the SEC filing context, Heinrich Dreismann is listed as a Director of Mainz Biomed N.V. in a document dated 2026-02-19. The filing confirms his board role but does not provide additional public biographical details (education, prior positions, etc.). Mainz Biomed N.V. is described in the context as a publicly traded life sciences company. The available information from the SEC filing is limited to his director role and the association with Mainz Biomed N.V.; no further personal background is available in the provided context.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | MYGN | MYRIAD GENETICS INC | A — Grant or award | 59.7K | $0.00 | |
| 2026-02-19 | QUCY | Quantum Cyber N.V. | A — Grant or award | 45.0K | $0.00 |
Based on the SEC filing context, Heinrich Dreismann is listed as a Director of Mainz Biomed N.V. in a document dated 2026-02-19. The filing confirms his board role but does not provide additional public biographical details (education, prior positions, etc.). Mainz Biomed N.V. is described in the context as a publicly traded life sciences company. The available information from…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dreismann Heinrich profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.